For: | Oh YH, Yoon C, Park SM. Bisphosphonate use and gastrointestinal tract cancer risk: Meta-analysis of observational studies. World J Gastroenterol 2012; 18(40): 5779-5788 [PMID: 23155320 DOI: 10.3748/wjg.v18.i40.5779] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i40/5779.htm |
Number | Citing Articles |
1 |
N. E. Morden, J. C. Munson, J. Smith, T. A. Mackenzie, S. K. Liu, A. N. A. Tosteson. Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury. Osteoporosis International 2015; 26(2): 663 doi: 10.1007/s00198-014-2925-9
|
2 |
Gurdeep Dulay, Elaine Dennison. What is needed to advance the treatment of osteoporosis in the UK?. International Journal of Clinical Rheumatology 2015; 10(5): 357 doi: 10.2217/ijr.15.31
|
3 |
Jennifer A Knopp-Sihota, Greta G Cummings, Joanne Homik, Don Voaklander. The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study. BMC Geriatrics 2013; 13(1) doi: 10.1186/1471-2318-13-36
|
4 |
Peter Vestergaard. The Duration and Safety of Osteoporosis Treatment. 2016; : 265 doi: 10.1007/978-3-319-23639-1_19
|
5 |
Masayoshi Yamaguchi, Robert M. Levy. Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro. Experimental and Therapeutic Medicine 2017; 14(2): 1769 doi: 10.3892/etm.2017.4695
|
6 |
Gemma Ibáñez-Sanz, Elisabet Guinó, Caridad Pontes, Rosa Morros, Luisa C. de la Peña-Negro, Mª Ángeles Quijada-Manuitt, Victor Moreno. Risk of colorectal cancer in users of bisphosphonates: analysis of population-based electronic health records. European Journal of Epidemiology 2020; 35(1): 37 doi: 10.1007/s10654-019-00584-5
|
7 |
Pia Eiken, Peter Vestergaard. Oral bisphosphonates and colon cancer: an update. Therapeutic Advances in Musculoskeletal Disease 2015; 7(4): 160 doi: 10.1177/1759720X15582144
|
8 |
Ellen Wright, Peter T Schofield, Mariam Molokhia. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis. BMJ Open 2015; 5(12): e007133 doi: 10.1136/bmjopen-2014-007133
|
9 |
Emily Vogtmann, Douglas A. Corley, Lucy M. Almers, Chris R. Cardwell, Liam J. Murray, Christian C. Abnet. Oral bisphosphonates and colorectal cancer. Scientific Reports 2017; 7(1) doi: 10.1038/srep44177
|
10 |
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Petra Lynen Jansen, Stephan Miehlke, Oliver Pech, Michael Stahl, Udo Vanhoefer, Matthias P.A. Ebert. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Zeitschrift für Gastroenterologie 2023; 61(06): e209 doi: 10.1055/a-1771-6953
|
11 |
Xiao Bai, Si-Qi Ding, Xue-Ping Zhang, Ming-Hao Han, Dong-Qiu Dai. Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses. Cancers 2023; 15(2): 372 doi: 10.3390/cancers15020372
|
12 |
Ji Yang, Min Song, Yiming Shen, Pan Ryu, So Lee. The Role of KV7.3 in Regulating Osteoblast Maturation and Mineralization. International Journal of Molecular Sciences 2016; 17(3): 407 doi: 10.3390/ijms17030407
|
13 |
Yuan-Yuan Li, Li-Jie Gao, Yu-Xue Zhang, Shu-Juan Liu, Shuo Cheng, Yu-Peng Liu, Cun-Xian Jia. Bisphosphonates and risk of cancers: a systematic review and meta-analysis. British Journal of Cancer 2020; 123(10): 1570 doi: 10.1038/s41416-020-01043-9
|
14 |
MANRU ZHOU, YAYUAN ZHENG, JIN LI, JINGKAI WU, WEIMING XU, LIAO CUI, WEIMIN YAO, YUYU LIU. Upper gastrointestinal safety and tolerability of oral alendronate: A meta-analysis. Experimental and Therapeutic Medicine 2016; 11(1): 289 doi: 10.3892/etm.2015.2848
|
15 |
M.H. Tao, S. Chen, J.L. Freudenheim, J.A. Cauley, K.C. Johnson, X. Mai, G.E. Sarto, H. Wakelee, P. Boffetta, J. Wactawski-Wende. Oral bisphosphonate use and lung cancer incidence among postmenopausal women. Annals of Oncology 2018; 29(6): 1476 doi: 10.1093/annonc/mdy097
|
16 |
D. Sanchez-Rodriguez, P. Bergmann, J.J. Body, E. Cavalier, E. Gielen, S. Goemaere, B. Lapauw, MR Laurent, S. Rozenberg, G. Honvo, C. Beaudart, O. Bruyère. The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women. Maturitas 2020; 139: 69 doi: 10.1016/j.maturitas.2020.05.006
|
17 |
Sun-Young Jung, Hyun Soon Sohn, Eun-Ja Park, Hae Sun Suh, Ji-Won Park, Jin-Won Kwon, Chi-Ling Chen. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea. PLOS ONE 2016; 11(3): e0150531 doi: 10.1371/journal.pone.0150531
|
18 |
Carlen Reyes, Mette Hitz, Daniel Prieto‐Alhambra, Bo Abrahamsen. Risks and Benefits of Bisphosphonate Therapies. Journal of Cellular Biochemistry 2016; 117(1): 20 doi: 10.1002/jcb.25266
|
19 |
Ying‐Ju Ou, Hui‐Fen Chiu, Yun‐Hong Wong, Yi‐Hsin Yang. Bisphosphonate use and the risk of endometrial cancer: a meta‐analysis of observational studies. Pharmacoepidemiology and Drug Safety 2016; 25(10): 1107 doi: 10.1002/pds.4075
|
20 |
Xiao-san Zhang, Yi-ming Zhang, Bin Li, Bo Fan, Yan Zhao, Shu-jun Yang. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis. Gynecologic Oncology 2018; 150(3): 509 doi: 10.1016/j.ygyno.2018.06.012
|
21 |
Gi Hyeon Seo, Hyung Jin Choi. Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study. Journal of Bone Metabolism 2015; 22(2): 77 doi: 10.11005/jbm.2015.22.2.77
|
22 |
D. Choi, S. Choi, J. Chang, S. M. Park. Exposure to oral bisphosphonates and risk of gastrointestinal cancer. Osteoporosis International 2020; 31(4): 775 doi: 10.1007/s00198-020-05327-x
|
23 |
Theodora Papamitsou, Antonios Morsi-Yeroyannis, Anastasios Papanastasiou, Nikolaos Bakalopoulos, Eva-Maria Dietrich, Sofia Karachrysafi, Alexandros Toskas, Evangelia Mareti, Anastasia Morsi-Yeroyanni, Antonia Sioga. Bisphosphonate’s Effect on Tongue Mucosa: An Experimental Electron Microscopy Study. Medicina 2020; 56(2): 51 doi: 10.3390/medicina56020051
|
24 |
Matthias P. Ebert, Wolfgang Fischbach, Stephan Hollerbach, Jens Höppner, Dietmar Lorenz, Michael Stahl, Martin Stuschke, Oliver Pech, Udo Vanhoefer, Rainer Porschen. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. Zeitschrift für Gastroenterologie 2024; 62(04): 535 doi: 10.1055/a-2239-9802
|